{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:30:36Z","timestamp":1778862636867,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002736","name":"Covidien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jcin.2015.09.008","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T14:39:59Z","timestamp":1451918399000},"page":"51-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions"],"prefix":"10.1016","volume":"9","author":[{"given":"Ricardo A.","family":"Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Abizaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Schofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard C.","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl E.","family":"Hauptmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Parise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Grube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2015.09.008_bib1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/CIRCINTERVENTIONS.109.891192","article-title":"New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems","volume":"3","author":"Abizaid","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2015.09.008_bib2","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.94.7.1690","article-title":"Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries","volume":"94","author":"van der Giessen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2015.09.008_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2015.09.008_bib4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications","volume":"115","author":"Luscher","year":"2007","journal-title":"Circulation"},{"issue":"Suppl C","key":"10.1016\/j.jcin.2015.09.008_bib5","first-page":"C7","article-title":"Pathophysiology of vascular healing and stent mediated arterial injury","volume":"4","author":"Nakazawa","year":"2008","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2015.09.008_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jbm.a.32057","article-title":"Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design","volume":"90","author":"Hezi-Yamit","year":"2009","journal-title":"J\u00a0Biomed Mater Res A"},{"key":"10.1016\/j.jcin.2015.09.008_bib7","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2015.09.008_bib8","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2015.09.008_bib9","first-page":"1047","article-title":"Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations","volume":"74","author":"Moussa","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2015.09.008_bib10","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/01.CIR.0000127129.94129.6F","article-title":"Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial","volume":"109","author":"Lansky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2015.09.008_bib11","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2008.01.020","article-title":"A\u00a0novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study","volume":"51","author":"Krucoff","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2015.09.008_bib12","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/eurheartj\/ehn253","article-title":"Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis","volume":"29","author":"Mehilli","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2015.09.008_bib13","first-page":"146","article-title":"Late clinical and angiographic follow-up of the new non-polymeric paclitaxel-eluting stent for the treatment of de novo coronary lesions: outcomes of the PAX-B study","volume":"20","author":"Abreu-Silva","year":"2012","journal-title":"Rev Bras Cardiol Invasiva"},{"key":"10.1016\/j.jcin.2015.09.008_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00228-010-0895-1","article-title":"The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: the Stealth PK Study","volume":"67","author":"Ostojic","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jcin.2015.09.008_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjcard.2006.02.051","article-title":"Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions","volume":"98","author":"Costa","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2015.09.008_bib16","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(08)61244-1","article-title":"Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial","volume":"372","author":"Windecker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2015.09.008_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2013.04.011","volume":"6","author":"Serruys","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2015.09.008_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIRCINTERVENTIONS.109.877522","article-title":"Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model","volume":"3","author":"Tada","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2015.09.008_bib19","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2015.09.008_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A\u00a0polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2015.09.008_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1540-8183.2007.00283.x","article-title":"Coronary stents, hypersensitivity reactions, and the Kounis syndrome","volume":"20","author":"Kounis","year":"2007","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jcin.2015.09.008_bib22","first-page":"253","article-title":"Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress","volume":"2","author":"Pendyala","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2015.09.008_bib23","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2015.09.008_bib24","first-page":"58","article-title":"A\u00a0randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial","volume":"1","author":"Serruys","year":"2005","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2015.09.008_bib25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jcin.2009.07.007","article-title":"Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial","volume":"2","author":"Meredith","year":"2009","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2015.09.008_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jbm.a.31787","article-title":"A\u00a0mathematical model for predicting drug release from a biodurable drug-eluting stent coating","volume":"87","author":"Hossainy","year":"2008","journal-title":"J\u00a0Biomed Mater Res A"},{"key":"10.1016\/j.jcin.2015.09.008_bib27","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jcin.2013.07.009","volume":"6","author":"Gada","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2015.09.008_bib28","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2015.09.008_bib29","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.amjcard.2006.05.020","article-title":"Twelve-month outcomes with a paclitaxel-eluting stent transitioning from controlled trials to clinical practice (the WISDOM Registry)","volume":"98","author":"Abizaid","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2015.09.008_bib30","first-page":"433","article-title":"Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry","volume":"72","author":"Lasala","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2015.09.008_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2015.09.008_bib32","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ahj.2013.01.008","article-title":"Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy","volume":"165","author":"Urban","year":"2013","journal-title":"Am Heart J"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879815013928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879815013928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:02:34Z","timestamp":1761847354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879815013928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1936879815013928"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2015.09.008","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2015.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}